Beam Therapeutics Files 8-K on Security Holder Vote

Ticker: BEAM · Form: 8-K · Filed: Jun 6, 2025

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

Beam Therapeutics filed an 8-K for a shareholder vote on June 4th. Details TBD.

AI Summary

Beam Therapeutics Inc. filed an 8-K on June 6, 2025, reporting on a matter submitted to a vote of its security holders on June 4, 2025. The filing does not disclose the specific details of the vote or the outcome, but it is a required disclosure for significant corporate actions.

Why It Matters

This filing indicates a significant corporate event requiring shareholder approval, which could impact the company's strategic direction or governance.

Risk Assessment

Risk Level: medium — The filing itself is procedural, but the underlying shareholder vote could represent a material event with significant implications for the company.

Key Players & Entities

FAQ

What specific matter was submitted for a vote of Beam Therapeutics' security holders on June 4, 2025?

The filing does not specify the exact matter submitted for a vote, only that a submission of matters to a vote of security holders occurred on June 4, 2025.

What is the Commission File Number for Beam Therapeutics Inc.?

The Commission File Number for Beam Therapeutics Inc. is 001-39208.

When is the reported date of this 8-K filing?

The 8-K filing is reported as of June 6, 2025.

Where are Beam Therapeutics Inc.'s principal executive offices located?

Beam Therapeutics Inc.'s principal executive offices are located at 238 Main Street, Cambridge, Massachusetts 02142.

What is the IRS Employer Identification Number for Beam Therapeutics Inc.?

The IRS Employer Identification Number for Beam Therapeutics Inc. is 81-5238376.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Beam Therapeutics Inc. (BEAM).

View full filing on EDGAR

View on Read The Filing